CRNX - Crinetics Pharmaceuticals Inc. (CRNX) CEO Scott Struthers on Q4 2020 Results - Earnings Call Transcript
Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2020 Earnings Conference Call March 30, 2021, 16:30 ET Company Participants Corey Davis - IR Scott Struthers - Founder, President, CEO & Director Alan Krasner - Chief Medical Officer Marc Wilson - CFO & Secretary Conference Call Participants Charles Duncan - Cantor Fitzgerald & Co. Tyler Van Buren - Piper Sandler & Co. Joori Park - SVB Leerink Douglas Tsao - H.C. Wainwright & Co. Daniel Wolle - JPMorgan Chase & Co. Presentation Operator Greetings. Welcome to the Crinetics Pharmaceuticals, Inc. 2021 Clinical Strategy and 2020 Financial Results Conference Call. [Operator Instructions]. I will now turn the conference over to your host, Corey Davis. You may begin. Corey Davis Thanks, Alex, and thank you all for participating in today's conference call. Before we start, I'd like to point out there is a slide deck that is going to accompany today's presentation. The deck can be
For further details see:
Crinetics Pharmaceuticals, Inc. (CRNX) CEO Scott Struthers on Q4 2020 Results - Earnings Call Transcript